Tailored Intervention to Improve Medication Adherence in Patients With Hypertension
- Conditions
- Hypertension
- Interventions
- Behavioral: Usual careBehavioral: Complex tailored intervention
- Registration Number
- NCT01742923
- Lead Sponsor
- Odense University Hospital
- Brief Summary
Patients with hypertension have an increased risk of stroke and myocardial infarction. However, poor adherence to treatment with antihypertensives and lipid-lowering agents occurs frequently within this patient group. The purpose of this study is to investigate whether a complex tailored intervention in a hospital setting will lead to increased medication adherence and fewer cardiovascular events when compared to a usual care group. Interventions focus on motivational interviewing, medication review and telephone follow up.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 532
Age: 18 years or older
- Patients receiving ambulatory treatment for hypertension in a hospital setting
- The patient or a carer usually dispenses the patient's medications
- Patient lives in the Southern Region of Denmark
- Written consent
- Lives in a care home or institution
- Receive dose dispensed medicine from a pharmacy
- Medicine is dispensed by a nurse in the patient's home
- Correctional mental health patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual care Usual care Usual care Complex tailored intervention Complex tailored intervention The interventions consists of 3 elements: 1. Medication review with recommendations focused on antihypertensives and statins and adherence to guidelines and patient´s adherence to medications 2. Consultation with a pharmacist using motivational interviewing techniques 3. Follow-up telephone calls one month and six months after inclusion
- Primary Outcome Measures
Name Time Method Percent of patients that are at least 80% adherent (Medication possession rate > 0.8) to antihypertensives and statins One year from inclusion
- Secondary Outcome Measures
Name Time Method Non-persistence with antihypertensives and statins measured by percent of patients that are not supplied with medications for more than three continuous months One year from inclusion Reduction in systolic and diastolic blood pressure One year from inclusion Composite endpoint (stroke, myocardial infarction or cardiovascular death) One year from inclusion
Trial Locations
- Locations (1)
Odense University Hospital
🇩🇰Odense C, Denmark